Therapeutic Response of Androgenetic Alopecia After Digital Drug Delivery with Application of Prodew 500®, Nanofactor® aFGF, Nanofactor® VEGF, Copper Peptide®, Prohairin B4®, Capillisil HC® and Arct-Alg®

    November 2021 in “ Revista Ibero-Americana de Humanidades, Ciências e Educação ”
    Mônica Ramos de Freitas, Rossana Cantanhede Farias de Vasconcelos, Jayme de Oliveira Filho
    Image
    Studysummary This paper evaluates the therapeutic response of androgenetic alopecia to topical application of specific compounds using digital drug delivery but reports no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.
    The document discusses a study on the therapeutic response of androgenetic alopecia (characterized by the progressive loss of hair follicles due to endocrine factors, genetic predisposition, and various biochemical disorders) after digital drug delivery. The treatment involved the topical application of Prodew 500®, Nanofactor® aFGF, Nanofactor® VEGF, Copper Peptídeo®, Prohairin B4®, Capillisil HC®, and Arct-Alg®. However, the document does not provide specific results or conclusions from the study.
    Discuss this study in the Community →